COHANCEPharmaceuticals
COHANCE LIFESCIENCES LTD — PE Ratio & Valuation Analysis
₹301.45
-1.13%
Current P/E61.57xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E50.6x21.7% above avg
⚠️
93.8% Premium to Industry
COHANCE P/E 61.57x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹10.45 | ₹529 | 50.6x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding COHANCE LIFESCIENCES LTD Valuation
COHANCE LIFESCIENCES LTD (COHANCE) currently trades at 61.57x earnings. The Pharmaceuticals sector average PE is 31.77x. COHANCE commands a premium, reflecting high growth expectations. Historically, COHANCE has traded at an average PE of 50.6x — it is currently above that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
12.67%
Dividend Yield
0.00%
More on COHANCE LIFESCIENCES LTD
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.